Skip to main content

Clinical & Experimental Metastasis

Ausgabe 2/2004

Inhalt (9 Artikel)

Cathepsin D expression levels in nongynecological solid tumors: Clinical and therapeutic implications

Gaetano Leto, Francesca M. Tumminello, Marilena Crescimanno, Carla Flandina, Nicola Gebbia

A small molecule antagonist of the α v β3 integrin suppresses MDA-MB-435 skeletal metastasis

John F. Harms, Danny R. Welch, Rajeev S. Samant, Lalita A. Shevde, Mary E. Miele, Geetha R. Babu, Steven F. Goldberg, Virginia R. Gilman, Donna M. Sosnowski, Dianalee A. Campo, Carol V. Gay, Lynn R. Budgeon, Robin Mercer, Jennifer Jewell, Andrea M. Mastro, Henry J. Donahue, Nuray Erin, Michael T. Debies, William J. Meehan, Amy L. Jones, Gabriel Mbalaviele, Allen Nickols, Neil D. Christensen, Robert Melly, Lisa N. Beck, Julia Kent, Randall K. Rader, John J. Kotyk, M.D. Pagel, William F. Westlin, David W. Griggs

Anti-metastatic properties of RGD-peptidomimetic agents S137 and S247

Kristen E. Shannon, Jeffery L. Keene, Steven L. Settle, Tiffany D. Duffin, Maureen A. Nickols, Marisa Westlin, Sally Schroeter, Peter G. Ruminski, David W. Griggs

Oncostatin M stimulates the detachment of a reservoir of invasive mammary carcinoma cells: Role of cyclooxygenase-2

Ryan G. Holzer, Randall E. Ryan, Matt Tommack, Eric Schlekeway, Cheryl L. Jorcyk

Angiogenic and antiangiogenic balance regulates concomitant antitumoral resistance

O. Graciela Scharovsky, M. Mercedes Binda, Viviana R. Rozados, Sunita Bhagat, Michael L. Cher, R. Daniel Bonfil

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.